Alibaba, China’s leading e-commerce company, has accused several reputation-protection agencies for making false accusations about the sale of fake goods and price fixing violations on its online shopping platform, calling for merchants to boycott those agencies.
In particular, Alibaba has named Chinese company Hangzhou Wangwei Technology, saying that it has decided to stop processing any complaints from the company. According to Alibaba, Wangwei has filed thousands of complaints, of which more than 60% since 2015 have ended up being withdrawn after counter-appeals from merchants.
“That rate is far beyond the normal,” said Alibaba in an online statement, adding that it has evidence suggesting that the agency, certain brand owners and distributors have joined together to lodge complaints against popular merchants for price-fixing and sales channel manipulation. Alibaba also pointed out that some agencies hired by global brands have gone as far as forging documents and making bad-faith registration of trademarks.
The damage to merchants from such activity can sometimes be irreversible, as Alibaba automatically removes products from sale when complaints are filed and while any appeal from the merchant is being processed. Some stores, according to Alibaba, have been forced to close down due to constant complaints about numerous products on their online stores filed by brand-protection agencies.
Alibaba said it would “not tolerate price-fixing on its platforms” and said it may pursue legal action if Hangzhou Wangwei continues with what it calls “malicious complaints against legitimate merchants.”
Full Content: Retail Dive
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas